Advertisement
Organisation › Details
Specialised Therapeutics Australia Pty Ltd. (STA)
Specialised Therapeutics Asia Pte Ltd (ST Asia) is an international biopharmaceutical company established to provide pioneering healthcare solutions to patients throughout South East Asia, as well as in Australia and New Zealand. The company is a close affiliate of Specialised Therapeutics Australia (STA), which also collaborates with leading global pharmaceutical and diagnostic companies to bring novel, innovative and life changing healthcare solutions to patients affected by a range of diseases. ST Asia is committed to making new and novel therapies available to patients around the world, with a broad therapeutic portfolio spanning oncology, hematology, urology and ophthalmology. *
Start | 2015-08-20 existent | |
Industry | pharmaceutical | |
Industry 2 | Abraxane™ | |
Person | Montagner, Carlo (200801– CEO + Founder of STA before Alchemia + Abraxas Bioscience et al + Schering 200510) | |
Street | 711 High Street Level 1 (PO Box 250) | |
City | 3102 East Kew VIC | |
Tel | 1300-798-820 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: PharmaMar S.A.. (5/17/17). "Press Release: PharmaMar and Specialised Therapeutics Asia Sign Licensing and Marketing Agreement for Lurbinectedin Covering Australia, New Zealand and Several Asian Countries". Madrid. | ||
Record changed: 2023-07-10 |
Advertisement
More documents for Specialised Therapeutics Australia Pty Ltd. (STA)
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top